Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomes.

Lee TC, Dhar VK, Hoehn RS, Wima K, Kim Y, Ertel AE, Patel SH, Shah SA.

Surgery. 2019 Jul 30. pii: S0039-6060(19)30405-2. doi: 10.1016/j.surg.2019.06.020. [Epub ahead of print]

PMID:
31375321
2.

Generation of Phosphoranyl Radicals via Photoredox Catalysis Enables Voltage-Independent Activation of Strong C-O Bonds.

Stache EE, Ertel AB, Tomislav R, Doyle AG.

ACS Catal. 2018 Dec 7;8(12):11134-11139. doi: 10.1021/acscatal.8b03592. Epub 2018 Oct 18.

PMID:
31367474
3.

Cyclin D1 integrates G9a-mediated histone methylation.

Li Z, Jiao X, Di Sante G, Ertel A, Casimiro MC, Wang M, Katiyar S, Ju X, Klopfenstein DV, Tozeren A, Dampier W, Chepelev I, Jeltsch A, Pestell RG.

Oncogene. 2019 May;38(22):4232-4249. doi: 10.1038/s41388-019-0723-8. Epub 2019 Feb 4.

4.

Torsional Impacts on Quaterthiophene Segments Confined within Peptidic Nanostructures.

Kale TS, Ardoña HAM, Ertel A, Tovar JD.

Langmuir. 2019 Feb 12;35(6):2270-2282. doi: 10.1021/acs.langmuir.8b03708. Epub 2019 Jan 29.

PMID:
30642185
5.

Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancer.

Bhatlekar S, Ertel A, Gonye GE, Fields JZ, Boman BM.

J Cell Physiol. 2019 Aug;234(8):13042-13056. doi: 10.1002/jcp.27975. Epub 2018 Dec 14.

PMID:
30552679
6.

Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE.

Cancer Discov. 2018 Dec;8(12):1654. doi: 10.1158/2159-8290.CD-18-1291. No abstract available.

PMID:
30510016
7.

Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.

Rodriguez-Bravo V, Pippa R, Song WM, Carceles-Cordon M, Dominguez-Andres A, Fujiwara N, Woo J, Koh AP, Ertel A, Lokareddy RK, Cuesta-Dominguez A, Kim RS, Rodriguez-Fernandez I, Li P, Gordon R, Hirschfield H, Prats JM, Reddy EP, Fatatis A, Petrylak DP, Gomella L, Kelly WK, Lowe SW, Knudsen KE, Galsky MD, Cingolani G, Lujambio A, Hoshida Y, Domingo-Domenech J.

Cell. 2018 Aug 23;174(5):1200-1215.e20. doi: 10.1016/j.cell.2018.07.015. Epub 2018 Aug 9.

8.

Accuracy of predicted orthogonal projection angles for valve deployment during transcatheter aortic valve replacement.

Steinvil A, Weissman G, Ertel AW, Weigold G, Rogers T, Koifman E, Buchanan KD, Shults C, Torguson R, Okubagzi PG, Satler LF, Ben-Dor I, Waksman R.

J Cardiovasc Comput Tomogr. 2018 Sep - Oct;12(5):398-403. doi: 10.1016/j.jcct.2018.05.017. Epub 2018 May 26.

PMID:
30064937
9.

Programmatic change leads to enhanced resource utilization and efficiency in port placement.

Venkatesan VK, McHenry ZD, Ertel AE, Ahmad SA, Sussman JJ, Hanseman D, Shah SA, Abbott DE.

J Surg Res. 2018 Sep;229:294-301. doi: 10.1016/j.jss.2018.04.030. Epub 2018 May 10.

PMID:
29937005
10.

Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.

Wang G, Gormley M, Qiao J, Zhao Q, Wang M, Di Sante G, Deng S, Dong L, Pestell T, Ju X, Casimiro MC, Addya S, Ertel A, Tozeren A, Li Q, Yu Z, Pestell RG.

Theranostics. 2018 Mar 11;8(8):2251-2263. doi: 10.7150/thno.23877. eCollection 2018.

11.

Blockade of Tumor-Expressed PD-1 promotes lung cancer growth.

Du S, McCall N, Park K, Guan Q, Fontina P, Ertel A, Zhan T, Dicker AP, Lu B.

Oncoimmunology. 2018 Jan 29;7(4):e1408747. doi: 10.1080/2162402X.2017.1408747. eCollection 2018.

12.

Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.

Lu H, Bowler N, Harshyne LA, Craig Hooper D, Krishn SR, Kurtoglu S, Fedele C, Liu Q, Tang HY, Kossenkov AV, Kelly WK, Wang K, Kean RB, Weinreb PH, Yu L, Dutta A, Fortina P, Ertel A, Stanczak M, Forsberg F, Gabrilovich DI, Speicher DW, Altieri DC, Languino LR.

Matrix Biol. 2018 Sep;70:20-35. doi: 10.1016/j.matbio.2018.03.009. Epub 2018 Mar 9.

13.

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE.

Cancer Discov. 2018 May;8(5):568-581. doi: 10.1158/2159-8290.CD-17-0699. Epub 2018 Mar 1. Erratum in: Cancer Discov. 2018 Dec;8(12):1654.

14.

Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer.

Thangavel C, Boopathi E, Liu Y, McNair C, Haber A, Perepelyuk M, Bhardwaj A, Addya S, Ertel A, Shoyele S, Birbe R, Salvino JM, Dicker AP, Knudsen KE, Den RB.

Clin Cancer Res. 2018 Mar 15;24(6):1402-1414. doi: 10.1158/1078-0432.CCR-17-2074. Epub 2018 Jan 8.

15.

The Chemokine Receptor CXCR3 Promotes CD8+ T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus Infection.

Caldeira-Dantas S, Furmanak T, Smith C, Quinn M, Teos LY, Ertel A, Kurup D, Tandon M, Alevizos I, Snyder CM.

J Immunol. 2018 Feb 1;200(3):1133-1145. doi: 10.4049/jimmunol.1701272. Epub 2017 Dec 29.

16.

Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy.

Vahidnezhad H, Youssefian L, Saeidian AH, Mahmoudi H, Touati A, Abiri M, Kajbafzadeh AM, Aristodemou S, Liu L, McGrath JA, Ertel A, Londin E, Kariminejad A, Zeinali S, Fortina P, Uitto J.

Matrix Biol. 2018 Mar;66:22-33. doi: 10.1016/j.matbio.2017.11.003. Epub 2017 Nov 11.

PMID:
29138120
17.

Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth.

Pestell TG, Jiao X, Kumar M, Peck AR, Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, Di Rocco A, Di Sante G, Katiyar S, Shupp A, Lisanti MP, Jain P, Wu K, Rui H, Hooper DC, Yu Z, Goldman AR, Speicher DW, Laury-Kleintop L, Pestell RG.

Oncotarget. 2017 Aug 4;8(47):81754-81775. doi: 10.18632/oncotarget.19953. eCollection 2017 Oct 10.

18.

Cost of achieving equivalent outcomes in sicker patients after liver transplant.

Dhar VK, Wima K, Kim Y, Hoehn RS, Jung AD, Ertel AE, Diwan TS, Paterno F, Shah SA.

HPB (Oxford). 2018 Mar;20(3):268-276. doi: 10.1016/j.hpb.2017.08.037. Epub 2017 Oct 4.

19.

Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database.

Chu BS, Koffi W, Hoehn RS, Ertel A, Shah SA, Ahmad SA, Sussman JJ, Neuman HB, Abbott DE.

J Surg Oncol. 2017 Dec;116(8):1176-1184. doi: 10.1002/jso.24766. Epub 2017 Jul 25.

20.

Nonresonant and Local Field Effects in Peptidic Nanostructures Bearing Oligo(p-phenylenevinylene) Units.

Ardoña HAM, Kale TS, Ertel A, Tovar JD.

Langmuir. 2017 Aug 1;33(30):7435-7445. doi: 10.1021/acs.langmuir.7b01023. Epub 2017 Jul 18.

PMID:
28683194
21.

Management and Outcome of Residual Aortic Regurgitation After Transcatheter Aortic Valve Implantation.

Koifman E, Didier R, Garcia-Garcia H, Weissman G, Ertel AW, Kiramijyan S, Steinvil A, Rogers T, Patel N, Kumar S, Tavil-Shatelyan A, Ben-Dor I, Pichard AD, Torguson R, Gai J, Satler LF, Waksman R.

Am J Cardiol. 2017 Aug 15;120(4):632-639. doi: 10.1016/j.amjcard.2017.05.033. Epub 2017 May 31.

PMID:
28673639
22.

Surgeon, not technique, defines outcomes after central venous port insertion.

Ertel AE, McHenry ZD, Venkatesan VK, Hanseman DJ, Wima K, Hoehn RS, Shah SA, Abbott DE.

J Surg Res. 2017 Mar;209:220-226. doi: 10.1016/j.jss.2016.10.030. Epub 2016 Nov 4.

PMID:
28032563
23.

RB Loss Promotes Prostate Cancer Metastasis.

Thangavel C, Boopathi E, Liu Y, Haber A, Ertel A, Bhardwaj A, Addya S, Williams N, Ciment SJ, Cotzia P, Dean JL, Snook A, McNair C, Price M, Hernandez JR, Zhao SG, Birbe R, McCarthy JB, Turley EA, Pienta KJ, Feng FY, Dicker AP, Knudsen KE, Den RB.

Cancer Res. 2017 Feb 15;77(4):982-995. doi: 10.1158/0008-5472.CAN-16-1589. Epub 2016 Dec 6.

24.

Case mix-adjusted cost of colectomy at low-, middle-, and high-volume academic centers.

Chang AL, Kim Y, Ertel AE, Hoehn RS, Wima K, Abbott DE, Shah SA.

Surgery. 2017 May;161(5):1405-1413. doi: 10.1016/j.surg.2016.10.019. Epub 2016 Dec 2.

PMID:
27919447
25.

Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages.

Vahidnezhad H, Youssefian L, Zeinali S, Saeidian AH, Sotoudeh S, Mozafari N, Abiri M, Kajbafzadeh AM, Barzegar M, Ertel A, Fortina P, Uitto J.

J Invest Dermatol. 2017 Mar;137(3):660-669. doi: 10.1016/j.jid.2016.10.023. Epub 2016 Oct 27.

26.

v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.

Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Andò S, Fatatis A, Lisanti MP, Gomella LG, Languino LR, Pestell RG.

Cancer Res. 2016 Nov 15;76(22):6723-6734. doi: 10.1158/0008-5472.CAN-15-3327. Epub 2016 Sep 15.

27.
28.

Addressing the High Costs of Pancreaticoduodenectomy at Safety-Net Hospitals.

Go DE, Abbott DE, Wima K, Hanseman DJ, Ertel AE, Chang AL, Shah SA, Hoehn RS.

JAMA Surg. 2016 Oct 1;151(10):908-914. doi: 10.1001/jamasurg.2016.1776.

PMID:
27464312
29.

Variability in postoperative resource utilization after pancreaticoduodenectomy: Who is responsible.

Ertel AE, Wima K, Hoehn RS, Chang AL, Hohmann SF, Ahmad SA, Sussman JJ, Shah SA, Abbott DE.

Surgery. 2016 Dec;160(6):1477-1484. doi: 10.1016/j.surg.2016.08.031. Epub 2016 Oct 4.

PMID:
27712874
30.

Cell cycle-coupled expansion of AR activity promotes cancer progression.

McNair C, Urbanucci A, Comstock CE, Augello MA, Goodwin JF, Launchbury R, Zhao SG, Schiewer MJ, Ertel A, Karnes J, Davicioni E, Wang L, Wang Q, Mills IG, Feng FY, Li W, Carroll JS, Knudsen KE.

Oncogene. 2017 Mar 23;36(12):1655-1668. doi: 10.1038/onc.2016.334. Epub 2016 Sep 26.

31.

Surgeon Characteristics Supersede Hospital Characteristics in Mortality After Urgent Colectomy.

Hoehn RS, Hanseman DJ, Chang AL, Daly MC, Ertel AE, Abbott DE, Shah SA, Paquette IM.

J Gastrointest Surg. 2017 Jan;21(1):23-32. doi: 10.1007/s11605-016-3254-4. Epub 2016 Sep 1.

PMID:
27586190
32.

Management of gastrointestinal bleeding in patients with cirrhosis.

Ertel AE, Chang AL, Kim Y, Shah SA.

Curr Probl Surg. 2016 Aug;53(8):366-95. doi: 10.1067/j.cpsurg.2016.06.006. Epub 2016 Jun 27. Review. No abstract available.

PMID:
27585818
33.

The impact of morbid obesity on resource utilization after renal transplantation.

Kim Y, Chang AL, Wima K, Ertel AE, Diwan TS, Abbott DE, Shah SA.

Surgery. 2016 Dec;160(6):1544-1550. doi: 10.1016/j.surg.2016.07.026. Epub 2016 Aug 26.

34.

Use of video-based education and tele-health home monitoring after liver transplantation: Results of a novel pilot study.

Ertel AE, Kaiser TE, Abbott DE, Shah SA.

Surgery. 2016 Oct;160(4):869-876. doi: 10.1016/j.surg.2016.06.016. Epub 2016 Aug 4.

PMID:
27499142
35.

Hospital resources are associated with value-based surgical performance.

Hoehn RS, Hanseman DJ, Go D, Wima K, Chang A, Ertel AE, Shah SA, Abbott DE.

J Surg Res. 2016 Jul;204(1):15-21. doi: 10.1016/j.jss.2016.04.024. Epub 2016 Apr 23.

PMID:
27451862
36.

Genome-wide redistribution of MeCP2 in dorsal root ganglia after peripheral nerve injury.

Manners MT, Ertel A, Tian Y, Ajit SK.

Epigenetics Chromatin. 2016 Jun 7;9:23. doi: 10.1186/s13072-016-0073-5. eCollection 2016.

37.

Mixed Transitional Liver Cell Tumor in a 23-Year-Old Female: A Case Report.

Ertel AE, Fu B, Shah SA.

Semin Roentgenol. 2016 Apr;51(2):123-5. doi: 10.1053/j.ro.2016.02.006. Epub 2016 Feb 5. No abstract available.

PMID:
27105967
38.

Surgical Approaches to Hepatocellular Carcinoma.

Ertel AE, Shah SA.

Semin Roentgenol. 2016 Apr;51(2):88-94. doi: 10.1053/j.ro.2016.02.004. Epub 2016 Feb 3. Review. No abstract available.

PMID:
27105963
39.

Risk of Reoperation Within 90 Days of Liver Transplantation: A Necessary Evil?

Ertel AE, Wima K, Chang AL, Hoehn RS, Hohmann SF, Edwards MJ, Abbott DE, Shah SA.

J Am Coll Surg. 2016 Apr;222(4):419-28. doi: 10.1016/j.jamcollsurg.2016.01.007. Epub 2016 Jan 23.

PMID:
26905185
40.

Gall Bladder Cancer.

Ertel AE, Bentrem D, Abbott DE.

Cancer Treat Res. 2016;168:101-20. Review.

PMID:
29206367
41.

A 28-year-old man with chest and joint pains.

Ertel AW, Romano S, Farzaneh-Far A.

Heart. 2016 May 15;102(10):808. doi: 10.1136/heartjnl-2015-308863. Epub 2015 Dec 29.

PMID:
26715568
42.

Hospital Utilization of Nationally Shared Liver Allografts from 2007 to 2012.

Ertel AE, Wima K, Hoehn RS, Abbott DE, Shah SA.

World J Surg. 2016 Apr;40(4):958-66. doi: 10.1007/s00268-015-3357-1.

PMID:
26643514
43.

Cost-Effectiveness in Hepatic Lobectomy: the Effect of Case Volume on Mortality, Readmission, and Cost of Care.

Sutton JM, Hoehn RS, Ertel AE, Wilson GC, Hanseman DJ, Wima K, Sussman JJ, Ahmad SA, Shah SA, Abbott DE.

J Gastrointest Surg. 2016 Feb;20(2):253-61. doi: 10.1007/s11605-015-2964-3. Epub 2015 Oct 1.

PMID:
26427373
44.

Increased myocardial extracellular volume in active idiopathic systemic capillary leak syndrome.

Ertel A, Pratt D, Kellman P, Leung S, Bandettini P, Long LM, Young M, Nelson C, Arai AE, Druey KM.

J Cardiovasc Magn Reson. 2015 Aug 27;17:76. doi: 10.1186/s12968-015-0181-6.

45.

Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base.

Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE.

J Gastrointest Surg. 2015 Oct;19(10):1794-801. doi: 10.1007/s11605-015-2922-0. Epub 2015 Aug 21.

PMID:
26293376
46.

Disparities in care for patients with curable hepatocellular carcinoma.

Hoehn RS, Hanseman DJ, Jernigan PL, Wima K, Ertel AE, Abbott DE, Shah SA; Cincinnati Research in Outcomes and Safety in Surgery (CROSS).

HPB (Oxford). 2015 Sep;17(9):747-52. doi: 10.1111/hpb.12427.

47.

Quantitative reflectance spectra of solid powders as a function of particle size.

Myers TL, Brauer CS, Su YF, Blake TA, Tonkyn RG, Ertel AB, Johnson TJ, Richardson RL.

Appl Opt. 2015 May 20;54(15):4863-75. doi: 10.1364/AO.54.004863.

PMID:
26192525
48.

Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database.

Manzotti G, Parenti S, Ferrari-Amorotti G, Soliera AR, Cattelani S, Montanari M, Cavalli D, Ertel A, Grande A, Calabretta B.

Cell Cycle. 2015;14(16):2578-89. doi: 10.1080/15384101.2015.1033591. Epub 2015 Jun 23.

49.

Organ quality metrics are a poor predictor of costs and resource utilization in deceased donor kidney transplantation.

Stahl CC, Wima K, Hanseman DJ, Hoehn RS, Ertel A, Midura EF, Hohmann SF, Paquette IM, Shah SA, Abbott DE.

Surgery. 2015 Dec;158(6):1635-41. doi: 10.1016/j.surg.2015.05.014. Epub 2015 Jun 19.

PMID:
26096564
50.

Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.

Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT.

Mol Cancer Ther. 2015 Aug;14(8):1777-93. doi: 10.1158/1535-7163.MCT-14-0883. Epub 2015 May 29.

Supplemental Content

Support Center